Value20202021202220232024TTMCash from investing activities-7.26 M11.78 M9.7 M10.58 M8.03 M5.3 MCash from financing activities61.4 M7.5 M8.02 M8.84 M9.53 M—Free cash flow-31.28 M-36.78 M-23.12 M-18.34 M-19.83 M-22.01 M
Pluri Inc
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas.